Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details Narrative)

v3.24.1.1.u2
NON CONTROLLING INTEREST (Details Narrative)
1 Months Ended
Oct. 31, 2020
Jul. 28, 2016
BioCorRx Pharmaceuticals, Inc [Member]    
Ownership percentage held by company   75.80%
Ownership percentage held by former officers   24.20%
Joseph DeSanto MD [Member]    
Descirption of management services agreement a management fee equal to 65% of the Medical Corporation’s gross collected monthly revenue